stockrow
Saturday 7 November 2026
Export MLEC’s income statement to Excel — free account
Moolec Science SA
MLEC Healthcare Biotechnology
Moolec Science SA’s revenue for fiscal 2025 (year ended June 2025) was $333.6 million, up 5,830.7% from fiscal 2024.
- Revenue
- +948.4%
- EPS
- −20.0%
- Free cash flow
- +4.48%
Quarter to December 2025, against a year earlier
0.85
0.00
0.00%
Follow MLEC
Alert me
| Jun '25 | Jun '24 | Jun '23 | Jan '23 | Jun '22 | Dec '21 | Jan '21 | Dec '20 | Jun '20 | Jan '20 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | — | — | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
3.14 | 7.51 | 0.00 | 0.00 | — | — | — | — | — | — |
Altman Z-Score |
(1.92) | 0.12 | 0.81 | 2,685.94 | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(12.04) | 0.59 | (11.03) | (12.83) | — | — | — | — | — | — |
P/FCF ratio |
1.35 | 2.87 | 0.00 | 0.00 | — | — | — | — | — | — |
Beneish M-Score |
89.08 | 20.95 | — | — | — | — | — | — | — | — |
P/Operating CF |
(27.58) | 0.88 | (52.70) | (477.50) | — | — | — | — | — | — |
P/B ratio |
8.78 | 0.17 | 13.89 | 0.00 | — | — | — | — | — | — |
Dividend Safety Score |
0 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 105.15 | 0.00 | — | — | — | — | — | — |
EV/Sales |
5.69 | 75.61 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/EBITDA |
1.19 | 11.43 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
1.03 | 10.75 | (18.67) | (192.04) | — | — | — | — | — | — |
EV/FCF |
2.46 | 28.92 | (18.67) | (192.04) | — | — | — | — | — | — |
Quick Ratio |
0.12 | 0.73 | 0.36 | 0.36 | 0.26 | 0.12 | 0.12 | 0.02 | — | 0.02 |
Current Ratio |
0.13 | 1.03 | 0.42 | 0.42 | 0.27 | 0.14 | 0.14 | 1.04 | — | 0.02 |
Net Debt/EBITDA |
(2.73) | 10.30 | 0.03 | 0.03 | 0.30 | 0.01 | 0.01 | (8.62) | 0.00 | (20.93) |
Debt/Assets |
120.54% | 47.45% | 11.00% | 11.00% | 0.00% | 0.09% | 0.09% | 40.01% | 0.00% | 94.43% |
Debt/Equity |
(2.98) | 1.80 | 0.26 | 0.26 | 0.00 | (0.04) | 0.00 | 10.08 | — | 23.79 |
Asset Turnover |
0.58 | 0.01 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
(0.03) | (5.41) | 0.15 | 0.15 | 0.42 | 9.76 | 9.76 | 0.64 | (0.36) | 0.64 |
Capex/Depreciation |
(0.83) | (1.38) | (1.47) | 0.00 | 0.00 | — | — | — | 0.00 | — |
Interest Coverage |
(2.49) | 0.51 | (41.59) | (18.94) | (1,739.24) | — | 0.00 | — | — | — |
| (133.38%) | (5.62%) | (884.51%) | 0.00% | 587.91% | 5.99% | 0.00% | (111.29%) | 0.00% | (111.29%) | |
| (19.31%) | (1.50%) | (348.24%) | 0.00% | (6.29%) | (0.14%) | 0.00% | (4.46%) | (4.46%) | (8.83%) | |
ROIC |
(42.03%) | 1.90% | (41.93%) | 0.00% | (436.89%) | 0.00% | 0.00% | (6.57%) | 0.00% | 0.00% |
Return on Tangible Assets |
55.31% | (8.56%) | 845.49% | 851.58% | 151.17% | 9.78% | 9.78% | (111.29%) | 0.00% | 4.70% |
Average Days of Receivables |
21.81 | 15,853.32 | 682.13 | 682.13 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
4.54% | 309.73% | 149.30% | 149.12% | 0.00% | — | — | — | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
37.74% | 2,246.01% | 559.68% | 548.97% | 0.00% | — | 0.00% | — | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.37 | 0.30 | 0.36 | 0.36 | 0.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.31% | 252.43% | 4,839.80% | 0.00% | 0.00% | — | — | — | — | — |
Graham Net Nets |
(0.78) | (6.20) | (0.06) | (0.11) | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(34.38%) | (17.71%) | (44.77%) | (17.62%) | — | — | — | — | — | — |
Free Cash Flow Yield |
73.86% | 34.83% | (5.35%) | (0.52%) | — | — | — | — | — | — |
Revenue per Share |
774.28 | 22.28 | 3.94 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Operating CF per Share |
8.44 | 156.68 | (32.67) | (0.22) | (9.12) | (38.61) | (0.05) | (0.43) | 0.00 | 0.00 |
Capex per Share |
(33.02) | (97.79) | (0.78) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(24.58) | 58.89 | (33.45) | (0.22) | (9.12) | (38.61) | (0.05) | (0.43) | 0.00 | 0.00 |
Cash per Share |
20.94 | 268.00 | 12.33 | 0.08 | 5.23 | 5.79 | 0.01 | 0.29 | — | 0.00 |
Shareholders Equity per Share |
(192.34) | 990.23 | 43.96 | 0.29 | 7.76 | (132.67) | 7.76 | 0.60 | — | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Book value per Share |
(192.34) | 990.23 | 43.96 | 0.29 | 7.76 | (132.67) | 7.76 | 0.60 | — | 0.00 |
Free Cash Flow |
(10.59) | 14.87 | (7.69) | (7.54) | (1.89) | (0.92) | (0.92) | (0.01) | 0.01 | (0.01) |
Working Capital |
(204.86) | 10.80 | (7.27) | (7.27) | (3.00) | (0.96) | (0.96) | 0.01 | — | (0.29) |
Capital Expenditures |
(14.23) | (24.69) | (0.18) | (0.18) | — | — | — | — | 0.00 | — |
Net Current Asset Value |
(256.39) | (261.63) | (8.61) | (8.61) | (3.00) | (141.16) | (3.16) | 0.01 | — | (0.29) |
EV/EBIT |
2.32 | 22.05 | 0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.04 | 4.39 | 0.20 | 0.00 | — | — | — | — | 0.00 | — |
Price to Operating Income |
1.28 | 2.19 | 0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.15 | 0.24 | 0.11 | 0.10 | 0.19 | — | — | — | 0.00 | — |
Cash ROIC |
(6.12%) | 1.94% | (49.35%) | (48.35%) | (70.21%) | 31.75% | (0.68%) | (6.13%) | 0.00% | (2.81%) |
Accounts Receivable Turnover |
2.52 | 0.05 | 0.54 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
2.31 | 3.17 | 0.24 | 0.00 | — | — | — | — | — | — |
Inventory Turnover |
3.17 | 4.41 | 2.25 | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
13.14 | 220.72 | 2,604.02 | 1,045.57 | 0.00 | — | — | — | — | — |
Days of Inventory on Hand |
4.01 | 164.91 | 162.13 | 156.39 | — | — | — | — | — | — |
Average Receivables |
132.13 | 123.01 | 1.69 | — | — | — | — | — | — | — |
Average Payables |
88.13 | 88.21 | 4.35 | 2.17 | — | — | — | — | — | — |
Average Inventory |
64.23 | 63.34 | 0.47 | — | — | — | — | — | — | — |
Average Assets |
577.27 | 486.94 | 14.87 | 14.87 | 71.93 | 69.24 | 69.24 | 0.31 | 0.31 | 0.16 |
Average Common Equity |
83.56 | 130.05 | 5.86 | 5.86 | (0.77) | (1.57) | 67.43 | 0.01 | — | 0.01 |
Columns are period end dates · fundamentals updated 26 Oct 2026